In a special focus on Commercial Influencers, PharmaVOICE Editor Taren Grom sat down with EVERSANA’s Chief Revenue Officer Greg Skalicky to discuss approaches to commercial strategies and how disruptive companies are changing the market to better reach and engage patients. The conversation covered commercialization trends, how the industry has changed in the last few years, what is driving innovation within solution providers and small- to mid-size pharmaceutical companies, the role of technology, choosing the right commercialization partner, and the importance of transparency and cultural fit.
Click to read the story online
Author Team
EVERSANA Team
EVERSANA employs a team of over 2500 professionals across 27 locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter the most to our clients and perform superior services that create value across the product life cycle.